Bio-Techne Investor Relations Material
Latest events
Q4 2025
Bio-Techne
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bio-Techne Corporation
Access all reports
Bio-Techne Corporation develops, manufactures, and sells life sciences research and clinical diagnostic products. The company’s portfolio includes proteins, antibodies, reagents, and diagnostic instruments supporting academic research, biopharmaceutical production, and clinical testing. Bio-Techne serves scientists and healthcare providers globally. The company is headquartered in Minneapolis, Minnesota, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
TECH
Country
🇺🇸 United States